Health passports, distancing tools among COVID-19 tech climbing Gartner Hype Cycle

Gartner research’s famous hype curve looks like a steep roller coaster leading to a launch pad. Beginning with the necessity-is-the-mother-of-innovation “Innovation Trigger,” it predictively tracks new technologies as they might evolve over the next years and decades: a long, slow climb the Peak of Inflated Expectations, then falling with a reality check into the Trough of Disillusionment, before slowly, with […]

» Read more

Nicotine withdrawal in zebrafish offers clues to human addiction

Researchers have identified nicotine-induced withdrawal for the first time in the zebrafish model—a discovery that could be used to test ways of treating withdrawal from addiction in humans. Trevor Hamilton, an adjunct professor in the Faculty of Science and member of the Neuroscience and Mental Health Institute at the University of Alberta, examined the role of nicotine exposure on zebrafish. […]

» Read more

Q&A: Researchers answer questions about their COVID modeling tool and share advice for future forecasters

Earlier this Summer we covered the work of Viktor Prasanna, the Charles Lee Powell Chair in the Ming Hsieh Department of Electrical and Computer Engineering, and USC Viterbi senior research associate Ajitesh Srivastava who works in the Data Science Lab headed by Prasanna. The two, who have extensive experience in epidemic forecasting, had begun using some of their unique models […]

» Read more

Moscow DOH uses AI platform to detect lung cancer symptoms

Botkin.AI, a Russian software platform has been integrated with the Unified Radiological Information System of Moscow, allowing CT studies from 46 medical organisations connected to the service to be automatically downloaded for analysis. Further it is planned that a large number of scans, implemented during the COVID-19 pandemic will be retrospectively reviewed with the help of Botkin.AI platform, using a new […]

» Read more

Can women with early breast cancer skip post-op radiation?

(HealthDay)—Instead of weeks of radiation following a lumpectomy, a new study shows that many women with early breast cancer do just as well with only a single dose of targeted radiation that is given during their surgery. “Breast cancer outcomes, in terms of cancer coming back, breast cancer survival, dying from breast cancer, being mastectomy-free, being free of disease elsewhere […]

» Read more

A metabolic enzyme as a potential new target for cancer immune therapies

The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This was discovered by scientists at the German Cancer Research Center (DKFZ) and the Berlin Institute of Health (BIH). The enzyme that activates the dioxin receptor is produced in large quantities by tumor cells. In the future, substances that inhibit IL4I1 could open up […]

» Read more

International team identifies a new regulatory pathway in bladder cancer

Researchers from Johns Hopkins University in collaboration with Insilico Medicine announce the publication of a new research paper titled “GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma” in Science Signaling. The KEAP1-NRF2 pathway plays a key role in cancer prevention and protective cellular responses to oxidative and electrophilic stress. In normal and premalignant tissues the signaling pathways activated by […]

» Read more

Illinois rapid saliva test for COVID-19 now operating under FDA Emergency Use Authorization

The University of Illinois, Urbana-Champaign is now performing its new rapid, saliva-based COVID-19 test under the umbrella of an approved FDA Emergency Use Authorization. The CLIA-certified lab at the U. of I. performed a bridging study to a recently approved FDA EUA, showing that the Illinois test performs at least as well as the recently approved saliva-testing protocol. “Direct saliva […]

» Read more
1 1,177 1,178 1,179 1,180 1,181 1,330